Elderly at risk of hospitalizations from key medications

Promoting safe use of blood thinners and diabetes medications can protect patients

 

Atlanta, GA, USA (November 23, 2011) – Each year, there are nearly 100,000 emergency hospitalizations for adverse drug events in U.S. adults aged 65 years or older, according to a Centers for Disease Control and Prevention study published today in the New England Journal of Medicine . Of the thousands of medications available to patients, a small group of blood thinners and diabetes medications caused two–thirds of the emergency hospitalizations, the report said.

 

“These data suggest that focusing safety initiatives on a few medicines that commonly cause serious, measurable harms can improve care for many older Americans,” said Dan Budnitz, M.D., M.P.H., director of CDC′s Medication Safety Program. “Blood thinners and diabetes medicines often require blood testing and dosing changes, but these are critical medicines for older adults with certain medical conditions. Doctors and patients should continue to use these medications but remember to work together to safely manage them.”

 

The study used data collected between 2007 and 2009 from a nationally representative sample of 58 hospitals participating in CDC′s National Electronic Injury Surveillance System–Cooperative Adverse Drug Event Surveillance project. Almost half (48.1 percent) of these hospitalizations occur among adults aged 80 years or older, and two–thirds (65.7 percent) of the hospitalizations were due to overdoses, or to situations in which patients may have taken the prescribed amount of medication but the drug had more than the intended effect on the patient′s body.

 

Four medications, used alone or together, accounted for two–thirds of the emergency hospitalizations:

  • 33 percent, or 33,171 emergency hospitalizations, involved warfarin , a medication used to prevent blood clots.
  • 14 percent involved insulin s. Insulin injections are used to control blood sugar in people who have diabetes.

 

This study identified specific medication safety issues that provide the greatest opportunities for reducing patient harm and health care utilization today. Continued national monitoring of adverse drug events will be important as new medications are approved and become more commonly used.

 

CDC scientists noted medications currently identified by national quality measures as being high–risk or potentially inappropriate for older patients were rarely identified as the cause of emergency hospitalizations (1.2 percent and fewer than 6.6 percent, respectively).

 

“Policies and improvement programs to promote safe use of medications that most commonly cause serious, measureable harms can increase patient safety and reduce unnecessary hospitalizations and costs at the same time,” said Patrick Conway, M.D., M.Sc., chief medical officer of the Centers for Medicare & Medicaid Services and director of CMS′ Office of Clinical Standards and Quality. “We are working across the federal government to address common preventable adverse drug events through medication management, care transition programs , and other initiatives.”

 

One initiative, the Partnership for Patients , includes an effort to decrease the number of preventable rehospitalizations by 20 percent by the end of 2013. Older adults are nearly seven times as likely as younger people to have adverse drug events that require hospitalization. Hospitalizations for adverse drug events have the potential to increase as Americans live longer, have greater numbers of chronic conditions, and take more medications. Decreasing adverse drug events, including those from blood thinners and diabetes medications, is a key area of focus for the Partnership for Patients.

 

For more information about what CDC is doing to protect older adults from adverse drug events, visit www.cdc.gov/medicationsafety

 

CDC works 24/7 saving lives, protecting people from health threats, and saving money through prevention. Whether these threats are global or domestic, chronic or acute, curable or preventable, natural disaster or deliberate attack, CDC is the nation′s health protection agency.

 


 

Centers for Disease Control and Prevention, 23.11.2011 (tB).

MEDICAL NEWS

Fitness watches generate useful information, but increase patient anxiety
A new device provides added protection against COVID-19 during endoscopic…
81 million Americans lacking space or bathrooms to follow COVID…
Front-line physicians stressed and anxious at work and home
EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19…

SCHMERZ PAINCARE

Morbus Fabry mittels Datenanalysen aus dem PraxisRegister Schmerz aufspüren
Neandertaler besaßen niedrigere Schmerzschwelle
Deutscher Schmerz- und Palliativtag 2020 – ONLINE
Deutsche Gesellschaft für Schmerzmedizin fordert Anerkennung von Nicht-Psychologen in der…
DBfK: Besondere Rolle für Pflegeexpert/innen Schmerz – nicht nur in…

DIABETES

“Körperstolz”: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen
Fastenmonat Ramadan: Alte und neue Herausforderung für chronisch Erkrankte während…
Sanofi setzt sich für die Bedürfnisse von Menschen mit Diabetes…

ERNÄHRUNG

Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Fast Food, Bio-Lebensmittel, Energydrinks: neue Daten zum Ernährungsverhalten in Deutschland
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf

ONKOLOGIE

Darolutamid bei Prostatakarzinom: Hinweis auf beträchtlichen Zusatznutzen
Multiples Myelom: Wissenschaftler überprüfen den Stellenwert der Blutstammzelltransplantation
Neues zur onkologischen Supportiv- und Misteltherapie und aktuelle Kongress-Highlights zum…
Finanzierung der ambulanten Krebsberatung weiterhin nicht gesichert
Lungenkrebsscreening mittels Low-Dose-CT

MULTIPLE SKLEROSE

Geschützt: Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Bristol Myers Squibb erhält Zulassung der Europäischen Kommission für Ozanimod…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen

PARKINSON

Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Putzfimmel im Gehirn
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…